SPI ex SLI
4.299,42
PKT
+40,61
PKT
+0,95
%
Werbung
Analysen zu SPI ex SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
19.01.05 | OC Oerlikon Accumulate | Helvea | |
19.01.05 | Barry Callebaut Neutral | Helvea | |
19.01.05 | OC Oerlikon Neutral | Sarasin Research | |
21.01.05 | Clariant Kaufen | Helaba Trust | |
19.01.05 | OC Oerlikon Buy | Helvea | |
19.01.05 | Clariant Halten | Helaba Trust | |
20.01.05 | Baloise Outperform | Goldman Sachs | |
20.01.05 | Sulzer Buy | Helvea | |
20.01.05 | OC Oerlikon Accumulate | Helvea | |
20.01.05 | Rieter Buy | Helvea | |
24.01.05 | Baloise Reduce | Sal. Oppenheim | |
18.01.05 | Sulzer Buy | Sarasin Research | |
18.01.05 | OC Oerlikon Buy | Helvea | |
18.01.05 | Swiss Prime Site Neutral | Helvea | |
18.01.05 | Siegfried Neutral | Helvea | |
19.01.05 | Komax Neutral | Helvea | |
18.01.05 | Swiss Prime Site Neutral | Helvea | |
18.01.05 | Inficon Buy | Sarasin Research | |
14.01.05 | Clariant Outperform | HypoVereinsbank | |
17.01.05 | Swiss Prime Site Neutral | Sarasin Research | |
17.01.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
14.01.05 | Rieter Neutral | Credit Suisse First Boston | |
13.01.05 | Sulzer Buy | Sarasin Research | |
17.01.05 | Tecan (N) Neutral | Credit Suisse First Boston | |
04.01.05 | dormakaba Buy | Sarasin Research |